ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Daily assessment of oral mucositis during volumetric modulated arc therapy planning technique for head and neck cancer: risk factors and impact on nutritional status.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeTo examine the occurrence, timing, and radiation dose associated with oral mucositis (OM) and body weight change in patients who underwent head and neck radiotherapy (RT) using the Volumetric Modulated Arc Therapy (VMAT) technique. It was also investigated whether these side effects affected nutritional status.
methodsData regarding age, gender, tumor type, radiation doses, OM, weight loss, diet, and prescriptions for nasoenteral tubes and gastrostomy were collected retrospectively from 84 medical records of a single head and neck VMAT service.
resultsSevere OM was observed in 61.8% of patients, occurring at a median cumulative dose of 37.7 Gy. Severe OM was significantly associated with radiation doses to the oral cavity and with concurrent chemotherapy, the latter being identified as a predictive factor. A median body weight loss of 6.1 kg was found in the majority of patients. Severe OM was linked with weight loss and the need for artificial nutrition.
conclusionThe frequency of OM in the oral cavity was high in patients treated with VMAT, significantly impacting nutritional status. Radiation dose to the oral mucosa and concurrent chemotherapy were associated with severe OM.
Indexed as
Identifiers
40588605What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.